The 2026-2027 Ferdinand C. Valentine Fellowship Award application cycle is now open and due on January 20, 2026. 

Background

The New York Academy of Medicine’s Ferdinand C. Valentine Fellowship Award for Research in the Field of Urology was established in 1963 to support research training in the specialty of urology for individuals who have completed residency training (prior to the grant award period) acceptable to the American Board of Urology, and who intend to use research training for continued development of an academic career in urology.

Eligibility Requirements

Preference will be given to candidates who will pursue their fellowship at institutions in the greater New York area. Fellows will be required to commit no less than fifty percent of their time to the supported research. First-time applicants will be given preference and only in exceptional circumstances will the renewal of awards be considered. Applicants may apply for both the American Foundation for Urologic Disease and Valentine grants, but if awarded both, candidates may accept only one. Candidates must be United States citizens, permanent residents or have (at the time of application) a valid working visa that can be renewed (if required) through the period of the award.

Application Process

Applicants must complete an online application that requires uploading certain materials and forms:

1. A signed cover letter describing previous training and experience and how the proposed activities relate to the applicant’s projected career.
2. Your education and research experience (the online application contains a specific form to be uploaded and completed)
3. A description of project facilities (the online application contains a specific form to be uploaded and completed)
4. A project budget (the online application contains a specific form to be uploaded and completed)
5. A description of the applicant’s research career goals (the online application contains a specific form to be uploaded and completed)
6. A research proposal that includes the project title, applicant’s name, research site, introduction, specific aims, work done by others, work done by applicant, methods of procedure, significance, potential obstacles and relevant bibliography. This should not exceed four (4) pages, including diagrams, illustrations, bibliography and any other supplemental materials.
7. A curriculum vitae
8. A signed letter of support from applicant’s research sponsor detailing your career development plan, providing a description of the research environment and available research facilities to be provided for the proposed project, providing an analysis of your clinical and research training and affirming that the sponsor has evaluated and approved your proposed application
9. An NIH biosketch of the research sponsor (sample provided in the online application)
10. Documentation of IRB or IACUC protocol approval, proof of submission, or waiver (if applicable). The complete protocol is not required, only the appropriate approval or submission cover page. Approvals for pending protocols must be in place by the start of the grant. In the case of animal research, include a copy of the institution’s current HHS Animal Welfare Assurance approval or renewal letter, or a letter from the institution’s research administration office affirming that the animal facility complies with all federal standards and has been so certified.
11. Signed certification letter from your institutional Grants or Finance Office accepting responsibility for overseeing this grant and stating that the official accepts the conditions outlined in the Academy Patent Policy (policy available online for download).

Award Information

A one-year fellowship award of $50,000 is available for research commencing in July of the application year. The grant is made to the sponsoring institution for the direct support of the salary and research activities of the awardee. Indirect costs and fringe benefits are not paid by this program. Grant recipients are required to submit progress and financial reports to NYAM at the mid-point and end of the grant period. Failure to comply with reporting requirements may result in termination of the grant and refund of any award monies paid, and may negatively affect consideration of future applications from the grantee’s institution. In addition, it is expected that the results of the supported research will be submitted to a peer reviewed journal for publication. For all publications acknowledgment must be made of support from The Ferdinand C. Valentine Fellowship and The New York Academy of Medicine.

Apply Now

---

Current & Previous Recipients

2023 – 2024

Parwiz Abrahimi, MD, PhD
New York-Presbyterian/Weill Cornell Medical College
Development and optimization of novel cell therapy for bladder cancer

Kavita Gupta, MD
Montefiore Medical Center
Evaluating the Effect of High Power Lasers on Renal Temperature and Renal Injury During Intrarenal Surgery

2021 – 2022

Caroline Kang, MD, PhD
Weill Cornell Medicine
The role of ADCY2 in male infertility due to cryptorchidism

Alan Yaghoubian, MD
Massachusetts General Hospital
Use of Urinary Biomarkers to Quantify Degree of Renal Parenchymal and Urothelial Damage During Ureteroscopy and Percutaneous Nephrolithotomy
Research conducted at Icahn School of Medicine at Mount Sinai

2020-21

Johnathan Khusid, MD
Icahn School of Medicine at Mount Sinai
Clinical Significance of the Kidney Stone Proteome

Siva Venkat, MD
Weill Cornell College of Medicine
Targeting Endoplasmic Reticulum Stress and the Unfolded Protein Response in a Murine Bladder Cancer Model

2019-20

Richard Matulewicz, MD
NYU Langone/Bellevue Hospital
Development and validation of a novel biomarker based nomogram to risk stratify patients undergoing diagnostic evaluation for microscopic hematuria

2018-19

Russell Hayden, MD
Weill Cornell Medicine
The Role of Long Non-Coding RNAs in Male Infertility

Jennifer Reifsnyder, MD
Cohen’s Children’s Medical Center at Northwell Health
Noninvasive Detection of Potential for Renal Damage in Pediatric Patients with Vesicoureteral Reflux Using Dynamic Range Ultrasonography

2017-2018

Bradley Morgenstern, MD
Feinstein Institute for Medical Research
Dynamic Range Ultrasonography in Pediatric Urologic and Nephrologic Renal Diseases

2015-2016

David Golombos, MD
Weill Cornell Medical College
Mutational Analysis to Predict Prostate Cancer Aggressiveness

2014-2015

Padriac O’Malley, MD
Weill Cornell Medical College
Development of Novel Diagnostic Imaging Applications for Prostate Cancer

2013-2014

Matthew Wosnitzer, MD
Weill Cornell Medical College/NY-Presbyterian Hospital
The Role of Ubiquitin Specific Protease 26 (USP26) in Testicular Function and Male Infertility

2010-2011

Richard K. Lee, MD, MBA
The Joan & Sanford I. Weill Medical College of Cornell University
Nanoparticle-mediated Microwave Thermotherapy for the Treatment of Prostate Cancer

2009-2010

Gerald J. Wang, MD
New York Presbyterian Hospital, Weill Cornell Medical Center<
Applications of multiphoton microscopy in the diagnosis and evaluation of response to immunotherapy in human bladder cancer

2008-2009

Mauricio Davalos, MD
New York Medical College
Oxidative Renal Cell Injury Induced by Calcium Oxalate and Renoprotection with Antioxidants: A Possible Role of Oxidative Stress in Nephrolithiasis

Gerald Y. Tan, MD
Weill Medical College of Cornell University
Novel use of multiphoton microscopy & second-harmonic generation for intra-operative real-time flourescent imaging of peri-prostatic neural architecture during nerve-sparing radical prostatectomy to improve potency outcomes: a controlled study in a rat model

2007-2008

Stephen A. Boorjian, MD
Mayo Clinic
Expression of Inhibitory T Cell Coregulatory Molecules in Primary and Metastic Urothelial Cell Carcinoma of the Bladder

Howard H. Kim, MD
Weill Medical College of Cornell University
Investigation of the Pathophysiology of Leydig Cell Dysfunction and Impaired Spermatogenesis Using a Novel Mouse Varicocele Model

2006-2007

George J. Huang, MD
University of Southern California, Keck School of Medicine
Patterns of Care in Bladder Cancer: Emerging Trends Over Time

2005-2006

Ricardo R. Gonzalez, MD
Weill Medical College of Cornell University
Modulating Bladder Neuroinflammation: Investigating Potential Diagnostics and Therapeutics for Interstitial Cystitis

Richard Lee, MD
Children’s Hospital Boston
The Identification of a Urinary Biomarker of Upper Tract Obstruction Using Proteomic Analysis in a Neonatal and Adult Rat Model

2004-2005

Saurabh Agarwal, MD
New York Medical College<
Possible renoprotection against nephrotoxic agents by glutathione in rats: Role of specific glutathione-dependent enzyme

Michael P. Zahalsky, MD, MMS
Laboratory of David C. Page, MD, Whitehead Institute
Department of Biology, Massachusetts Institute of Technology and Howard Hughes Medical Institute
X-Linked Testis Genes and Human Spermatogenic Failure

2003-2004

David Yen Tang Chen, MD
New York Presbyterian-Weill Cornell Medical Center
Characterization of Neutral Endopeptidas – anti-PSMA mAb J591 Fusion Protein and Applications as Therapy for Advanced Prostate Cancer

Jeffrey Michael Donohoe, MD
Vanderbilt University Medical Center
Effects of Specific Angiotensin Receptor Subtype Blockade on Bladder Fibrosis

John Stephen Lam, MD (Honorable Mention)

David Geffen School of Medicine at UCLA
Characterization of Carbonic Anhydrase (CA IX) as a Tumor-Associated Antigen for Target-Directed Vaccine Therapy of Renal Cell Carcinoma

2002-2003

Assad El-Hakim, MD
Long Island Jewish Medical Center
Laparoscopic Bowel Injury: Evaluation of the Immune Response

Rosalia Misseri, MD
Indiana University School of Medicine
Determining the Hydrostatic Threshold for Bladder Injury

2001-2002

Carin V. Hopps, MD 
The New York Hospital-Cornell Medical Center
Molecular Investigation of Human Spermatogenesis

Albert A. Samadi, MD
New York Medical College
Mechanism of Cathepsin D Activation and Its Regulation in Prostate Cancer

Douglas S. Scherr, MD
Memorial Sloan-Kettering Cancer Center
The Role of p27 in Prostate Epithelial Cell Proliferation/Differentiation

2000-2001

No Fellowships awarded

1999-2000

Robert Soe-Hliang Lai, MD
Long Island Jewish Medical Center
Electric Neuromodulation in the Treatment of the Neurogenic Bladder Following Spinal Cord Injury

1998-1999

Badrinath R. Konety, MD 
University of Pittsburgh Cancer Institute
Molecular Characterization of a Novel Nuclear Matrix Protein Associated with Bladder Cancer

Mark B. Noss, MD, MSc 
Albert Einstein College of Medicine and Montefiore Medical Center
Immunogenetic Etiology of Peyronie’s Disease

1997-1998

Gary E. Lemack, MD
University of Texas – Southwestern Medical Center
Lower Urinary Tract Development and Physiology in Mice Lacking Inducible Nitric Oxide Synthase

The 2026-2027 Glorney-Raisbeck Fellowships Award in Cardiovascular Diseases Award application cycle is now open and due on January 20, 2026.

 

Background

The Glorney-Raisbeck Fellowships Award in Cardiovascular Diseases is awarded in support of research projects seeking better understanding of the causes, prevention and treatment of cardiovascular disease and that will advance the academic careers of young physician investigators.

Eligibility Requirements

Candidates must be enrolled in an ACGME-approved clinical training program in cardiovascular diseases or in an ACGME-approved residency that will qualify for a planned clinical cardiovascular diseases training program.  The proposed research must be conducted at institutions located in New York City, Long Island, or Westchester County, New York, and fellows must commit at least eighty percent of their time to the funded project.

Candidates must hold a MD or equivalent degree, must be United States citizens, permanent residents or have, at the time of application, a valid working visa that can be renewed (if required) through the period of the award.  Candidates on a working visa who receive the award should note that if their visa is not renewed at any point during the grant period, the award will be revoked and all funds required to be refunded to the grantor.

Renewal of awards to previous recipients will be considered on a competitive basis.

For those individuals who may not meet these criteria, please email the program at [email protected] and exceptional circumstances may be considered.

Selection Guidelines and Procedures

The Glorney-Raisbeck Selection Committee of The New York Academy of Medicine reviews all applications and supporting materials and recommends award recipients for ratification by the Trustees of the Academy. The review of applications will be weighed 25% on the applicant, 25% on the environment and 50% on the project. Additionally, the Committee’s evaluation will include that candidates be judged on their data analysis plan. A personal interview may be required. Candidates will be advised of their status by late March.

Application Process

Applicants must complete an online application that requires uploading certain materials and forms:

1. A signed cover letter describing previous training and experience and how the proposed activities relate to the applicant’s projected career.
2. A description of project facilities (the online application contains a specific form to be uploaded and completed)
3. A project budget (the online application contains a specific form to be uploaded and completed)
4. A description of the applicant’s research career goals (the online application contains a specific form to be uploaded and completed)
5. A research proposal that includes the project title, applicant’s name, research site, introduction, specific aims, work done by others, work done by applicant, methods of procedure, significance, potential obstacles and relevant bibliography. This should not exceed four (4) pages, including diagrams, illustrations, bibliography and any other supplemental materials.
6. A curriculum vitae
7. A signed letter of support from applicant’s research sponsor detailing your career development plan, providing a description of the research environment and available research facilities to be provided for the proposed project, providing an analysis of your clinical and research training and affirming that the sponsor has evaluated and approved your proposed application
8. An NIH biosketch of the research sponsor (sample provided in the online application)
9. A signed letter of recommendation from the department chair or division director at the institution where your research will take place, describing the facilities and faculty resources available for career development, explaining how the proposed research will prepare you for an academic career and affirming that he or she has evaluated and approved your proposed application.
10. Documentation of IRB or IACUC protocol approval, proof of submission, or waiver (if applicable). The complete protocol is not required, only the appropriate approval or submission cover page. Approvals for pending protocols must be in place by the start of the grant. In the case of animal research, include a copy of the institution’s current HHS Animal Welfare Assurance approval or renewal letter, or a letter from the institution’s research administration office affirming that the animal facility complies with all federal standards and has been so certified.
11. Signed certification letter from your institutional Grants or Finance Office accepting responsibility for overseeing this grant and stating that the official accepts the conditions outlined in the Academy Patent Policy (policy available online for download).

Award Information

One-year fellowship awards of $70,000 each are available for research commencing in July of the application year. Awards will be paid directly to the sponsoring institution. At least $55,000 of the grant must be dedicated to support the awardee’s salary. The remainder of the award may be used for fringe benefits and indirect costs (indirect costs may not exceed 15 percent). Laboratory expenses are not covered by this grant. Grant recipients are required to submit progress and financial reports to NYAM at the mid-point and end of the grant period. Failure to comply with reporting requirements may result in termination of the grant and refund of any award monies paid, and may negatively affect consideration of future applications from the grantee’s institution.

Apply Now

---

Current & Previous Recipients

2021 – 2022

Anton Camaj, MD

Outcomes After Complete Versus Incomplete Revascularization in Patients with Diabetes

Research conducted at Icahn School of Medicine at Mount Sinai

Edwin Homan, MD

Cardioprotective mechanisms of caloric restriction in mice with ischemic heart failure

Research conducted at NewYork-Presbyterian/Weill Cornell Medical Center

 

2020-21

Michael Hadley, MD

Cardiac Magnetic Resonance Imaging of Myocardial Fibrosis from Air Pollution

Research conducted at Icahn School of Medicine at Mount Sinai

Hannah Rosenblum, MD

Delineating Mechanisms Underlying the Efficacy of Emerging Therapies for Transthyretin Cardiac Amyloidosis with Noninvasive Pressure-Volume Relationships

Research conducted at Columbia University Irving Medical Center

2019-20

Bimmer Classen, MD

Risk of Adverse Coronary Thrombotic Events and Bleeding Events After Noncardiac Surgery in Patients with Coronary Artery Stents

Research conducted at Icahn School of Medicine at Mount Sinai

Jonathan Kochav, MD

Impact of Papillary-Ventricular Ischemiaon Functional Mitral Regurgitation – Integrated Tissue and Strain Based Assessment via Cardiac Magnetic Resonance

Research conducted at New York-Presbyterian Hospital/Columbia University Medical Center

Syed Saad Mahmood, MD

Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Immunotherapy for Cancer

Research conducted at New York-Presbyterian Hospital/Columbia University Medical Center

2018-2019

Jared S. Kushner, MD

Elucidating Mechanisms of Calcium Channel Regulation in the Heart

Research conducted at New York Presbyterian-Columbia University

2017-2018

Daniele Massera, MD

Markers of Bone Turnover and Risk of Incident Fractures, Aortic Stenosis and Diabetes Mellitus in Older Women

Research conducted at Montefiore Medical Center and Albert Einstein College of Medicine

Michael Garshick, MD

The Impact of Microbiome Alternations on Atherosclerotic Plaque Regression 

Research conducted at New York University Medical Center

2015-2016

Adam Castaño, MD

Technetium Pyrophosphate Cardiac Imaging to Determine if Transthyretin Cardiac Amyloidosis Explains Paradoxical Low-Flow Severe Aortic Stenosis

Research conducted at Columbia University

Amy Kontorovich, MD

Modeling Myocarditis with Human Induced Pluripotent Stem Cells

Research conducted at Mount Sinai Medical Center

Joshua Lader, MD

Mechanisms of K(ATP) Channel Activation in Adrenergically-Mediated Atrial Fibrillation

Research conducted at New York University School of Medicine

Nathaniel Langer, MD

The Role of Myostatin in Right Ventricular Dysfunction during Pressure Overload

Research conducted at Columbia University

2014-2015

Kanwal Farooqi, MD

Mount Sinai Medical Center

Creation and Validation of Low Cost 3D Cardiac Models from MRI in Patients with Congenital Heart Disease

2013-2014

Yongxia Sarah Qu, MD, PhD

SUNY Downstate Medical Center

Novel function of alpha1D L-type calcium channel in atria

Nisharahmed Kherada, MD

Mount Sinai Medical Center, Icahn School of Medicine

Antiplatelet Adherence Algorithm From Paris Registry

Matthew Egalka, MD

Columbia University Medical Center

Assessing the Thrombogenic Potential of Neonatal Platelets

2012-2013

Daria B. Crittenden, MD

NYU School of Medicine

Effects of Colchicine on Cardiovascular Disease: Colchicine Use and the Risk of Myocardial Infarction in Patients with Gout

2011-2012

Lori K. Soni, MD

Columbia University Medical Center

The TASK-1 Channel in Atrial Fibrillation as a Selective, Therapeutic Target

2010-2011

Usman Baber, MD

Mount Sinai School of Medicine

Impact of Chronic Kidney Disease on Blood Thromobogenicity and Response to Clopidogrel

Joshua M. Lader, MD

New York University School of Medicine

Arrhythmogenic Mechanism of K(ATP) Channel Activation in Hypertension

2009-2010

Steven F. Giovannone, MD

New York University School of Medicine

Developmental Gene Expression of the Purkinje Fiber Network

James R. Kneller, MD, MSc, PhD

New York University

Role of the Inflammatory Response to Radiofrequency Ablation of Atrial Fibrillation in Determining Ablation Efficacy

Constance G. Weismann, MD

Mount Sinai School of Medicine

RAF1 mutations causing Noonan Sydrome with hypertrophic cardiomyopathy characterization of phenotype in the fly model and identification of new treatment strategies with high-throughput pharmacological screen

2008-2009

Sammy Elmariah, MD

The Mount Sinai School of Medicine

Effects of Bisphosphonates on the Progression of Aortic Valve Calcification

Benjamin F. Remo, MD

New York University School of Medicine

The Role of Post-translational Phosphorylation of Gap Junction Proteins in Gap Junction Remodeling

2007-2008

Eugene E. Kim, MD

New York University School of Medicine

The Role of Cardiac Fibroblasts in Electrical Impulse Propagation

Roland S. Wu, MD

Columbia University College of Physicians and Surgeons

The Role of p27kip1 Phosphorylation in Vascular Smooth Muscle Proliferation and Migration

2006-2007

Rose S. Cohen, MD

Columbia University College of Physicians and Surgeons

The Effect of Erythropoietin on Left Ventricular Remodeling and Pressure-Volume Relationships in Patients with Anemia and Diastolic Heart Failure

2005-2006

Eric D. Adler, MD

Mount Sinai School of Medicine

Isolation and Functional Characterization of Cardiac Pacemaker Cells from Embryonic Stem Cell Derived Cardiac Precursor Cells

Elaine Y. Chiang, MD

Mount Sinai School of Medicine

Investigation of Leucocyte Recruitment in Sickle Cell Vasoocclusion

Prashant Kaul, MBBCh

Weill Medical College of Cornell University

The Role of the Rho Guanine Nucleotide Exchange Factor Lsc/p115 Rho GEF in Neutrophil Polarization and Chemotaxis

2004-2005

Nathalie D. Burg, MD

Rockefeller University

Platelet TGF-B1 Compartmentalization and Activation

Nellie I. Kalcheva, MD

New York University Medical Center

The Cardiac System and its Function in a Murine Model for Oculodentodigital Dysplasia (ODDD)

Alfonso F. J. Prieto, MD

Columbia University Medical Center

Electrophysiologic Characterization of a Mouse Model of Heart Failure and Cardiac Arrhythmias

2003-2004

Sanjeev Arokiasamy Francis, MD

Weill Medical College of Cornell University

Determining the Role of a Eeyore, a Novel Rho GEF in Macrophage Chemotaxis and Phagocytosis

Nikhil Vilas Munshi, MD, PhD

Columbia University College of Physicians and Surgeons

Molecular Determinants of Cardiac Conduction System Development

Xander Hennie Wehrens, M.D., Ph.D.

Columbia University College of Physicians and Surgeons

Functional Characterization of Ryanodine Receptor Type 2 Mutations Linked to Arrhythmogenic Right Ventricular Dysplasia Type 2 (ARVD2)

2002-2003

Quynh Anh Truong, MD

The Rockfeller University

Expression and Functional Analyses of a Novel Mouse Gene mhrp 1 and Its role in Atherosclerosis

William Jacob Mack, MD

Columbia University

Complement Mediated Injury in Murine Stroke

2001-2002

Sei Iwai, MD

Weill Medical College of Cornell University

A Molecular Genetic Basis For Familial Atrial Fibrillation

Kent M. Stephenson, MD

Mount Sinai Medical Center

Macrophages and Arterial Injury

Carrie M. Brownstein, MD

Weill Medical College of Cornell University

The Role of Annexin II in Monocyte and Macrophage Function

Renewal of Award 2001-2002

Charles J. Vaughen, MD

Weill Medical College of Cornell University

Molecular Genetic Analysis of Familial Aortic Aneurysms

2000-2001

Yi-Ming Yang, MD

New York-Presbyterian Medical Center

Phosphorylation and Dephosphorylation of the Cardiac IP3 Receptor

Charles J. Vaughan, MD

Weill Medical College of Cornell University

Molecular Genetic Analysis of Familial Aortic Aneurysms

1999-2000

No Fellowships Awarded

1998-1999

Hayes M. Dansky, MD

The Rockefeller University

HDL and Atherosclerosis

Detlef Wencker, MD

Albert Einstein College of Medicine

Role of Cardiac Myocyte Apoptosis in the Pathogenesis of Ischemic Injury

The 2026-2027 Glorney-Raisbeck Junior Faculty Research Award application cycle is now open and due on January 20, 2026.

Background

The goal of this new award from the New York Academy of Medicine is to support promising junior clinical/research faculty in Cardiology or Cardiothoracic Surgery as they prepare to submit NIH or AHA career development awards. The award is intended for applicants with demonstrable prior research experience (as reflected in first-authored publications) who have either applied for or are close to applying for a career development award from the NIH, AHA, or similar organization. Basic, translational, and clinical research projects will be considered. It is expected that≤20% of time and effort will involve provision of clinical services.

Eligibility Requirements

At the time of award activation (July 2021):

• Applicant must hold a faculty/staff position up to and including the rank of assistant professor (or equivalent).
• Applicant must have completed an ACGME-accredited cardiovascular medicine or cardiothoracic surgery fellowship
• No more than 2 years may have elapsed since the first faculty/staff appointment at the instructor or assistant professor level or equivalent
• A minimum 75% time commitment for research is required
• Applications may be submitted for review in the final year of fellowship as long as the applicant will be appointed to a faculty position at the Instructor, Research Assistant Professor, or Assistant Professor level by award activation
• The Faculty Research award cannot overlap at any time with a NIH or AHA career development award or similar award. If NIH, AHA or similar career development award is obtained during the funding period, remaining NYAM funds will need to be returned.

Application Process

Applicants must complete an online application that requires uploading certain materials and forms:

1. Career Development Plan (1 page maximum) – The applicant is required to submit a comprehensive career development plan that describes prior training and future career objectives.  In addition, describe how this award will help to develop your career as a funded investigator in cardiovascular sciences.
2. Research Plan (4 pages maximum)- The applicant is required to submit a comprehensive research proposal to include Aims, Hypotheses to be tested, Significance, Innovation, Background/Preliminary studies, and Approach section, appropriately scaled for feasibility in the 1 year period of the award.  Do not replicate an AHA or NIH proposal as this award is for only 1 year and cannot be renewed.  The research plan must include a statistical analysis plan which justifies sample sizes proposed and power (likelihood that the hypothesized result will be found if, indeed, the hypothesis is true).
3. Letters of recommendation: Department Chair and/or Division Chief, Research Supervisor and 1 additional letter of recommendation from faculty with knowledge of your research skills and potential.  Department Chair/Division Chief letter must include explicit statements regarding protected time to perform research and allocation of space (which does not need to be independent from mentor).
4. CV of Mentor and applicant (NIH format)
5. IRB/IACUC approval documentation is required at award activation

Award Information

Up to $85,000 inclusive of fringe benefits. Fringe Benefits and indirect costs can be up to 15% of the award. No equipment or supply support is available.

Apply Now

---

Current & Previous Recipients

2021-22

Timothy Poterucha, MD
Prospective Detection of Transthyretin Cardiac Amyloidosis using Deep Learning
The Trustees of Columbia University in the City of New York

Lili Zhang, MD
Racial Disparities in Anthracycline Cardiotoxicity
Montefiore Medical Center/Albert Einstein College of Medicine

2020-21

Syed Saad Mahmood, MD
Global longitudinal strain and cardiovascular events in patients receiving chimeric antigen receptor T-cell immunotherapy for cancer
Weill Cornell Medical College and New York Presbyterian Hospital

2019-20

Jared S. Kushner, MD
Prevention of Arrhythmia Through Disruption of CaV1.2 a-B Subunit Interaction
Columbia University Medical Center

Sasa Vukelic, MD
Prevention of Angiodysplasia Related Gastrointestinal Bleeding in CF-LVAD Patients – Role of Digoxin
Montefiore Medical Center and Albert Einstein College of Medicine

Click here to read a recent Q&A Blog Post with the 2016 Barondess Award Winner, Brian Garibaldi, MD, MEHP, FACP, FRCP (E)

Click here to see what past recipients of The Jeremiah A. Barondess Fellowship had to say about the impact of the Fellowship on their careers.

Introduction

The clinical transaction consists of three core skills that impact the patient-physician relationship: obtaining a comprehensive and accurate clinical history; performing a thorough and accurate physical examination; and engaging in a rigorous process of clinical reasoning from the data acquired through these techniques. During recent decades, there has been an erosion of the transmission to medical students, residents, and fellows of these critically important skills. There commonly are deficits in the ability of medical students, residents, and fellows to communicate with patients, conduct the physical examination, and apply clinical reasoning. Importantly, this has occurred in the face of major changes in clinical practice, driven by the aging of the population and an increased burden of chronic diseases. The complexity of patients requires well-developed clinical skills, substantial clinical sophistication, and appropriate use of technology. There is a need to energize medical education and post-graduate training in these basic clinical skills. While the importance of the clinical transaction has long been recognized in medical education, there remains a need to innovate and strengthen teaching of these critically important capacities. It also is widely recognized that physicians need training in the assessment of the social and environmental determinants of health, if they are to identify the root causes of health.

Furthermore, the COVID-19 pandemic resulted in challenges to both patient care and medical education. Adaptations to the pandemic, including remote medical care through telehealth and telephonic health and remote learning through webinars and virtual conferences, have resulted in both new opportunities and challenges for medical education and post-graduate training in these basic skills. The pandemic also increased the recognition of the need for medical education and post-graduate training to promote equitable health care, including access, utilization, quality, and outcomes, for all.

Jeremiah A. Barondess Fellowship

To honor the visionary role of Jeremiah A. Barondess, MD in medical education, and to recognize his teaching of clinical skills at the bedside to generations of medical students and residents, the New York Academy of Medicine established The Jeremiah A. Barondess Fellowship in the Clinical Transaction. The Fellowship will support one fellow with special interest and expertise in medical education related to the elements of the clinical transaction in 2026-2028. The fellow will develop, implement, and evaluate an innovative approach to educating medical students, residents, and/or fellows in elements of the clinical transaction. The Fellowship will also promote supportive institutional structures and processes, with a specific focus on building successful educational experiences related to the elements of the clinical transaction. Examples of responsive applications, with the names, institutions, and project titles of prior awardees, are listed at the end of this announcement.

The Barondess Fellowship is consistent with the need for improvement in clinical care competencies among internists, included in the ACGME Internal Medicine Milestones.  The Barondess Fellowship is intended to support systematic efforts to develop internists who, by the end of their education and training, have achieved the aspirational goals for internists related to the clinical transaction.

Fellowship Goals

The goals of the Fellowship are to enhance the quality of the clinical care through innovative and rigorous educational experiences related to the elements of the clinical transaction, to develop evidence of the power of the well-conducted clinical transaction, and to improve the patient experience in clinical care by emphasizing high clinical and technical competence of these elements as well as empathy and compassion. The Fellowship funding is intended to encourage departments of medicine to provide .20 FTE of protected time for a single recipient to address these goals within their institution.

Eligibility

Applications are invited from a medical school, department of medicine, and medical school-affiliated teaching hospitals with an approved internal medicine residency program in the United States. Candidates should have exemplary clinical skills and a commitment to innovative teaching and training focused on the development of excellence in the fundamental elements of clinical care that impact the patient-physician relationship. The Fellowship is for early-career (less than or equal to five years) faculty members with a regular university/faculty appointment (e.g., instructors and assistant professors), with key responsibilities for developing, implementing, directing, and teaching in a robust, innovative clinical education and training program.  Faculty members based at a medical school-affiliated Veterans Administration Hospital may apply.  Clinical fellows or senior residents in their last year of the program may apply, but must have a junior faculty position/university appointment at the start of the Fellowship funding period on July 1, 2026.

Note: An institution that was awarded a Barondess Fellowship in 2025-2027 is not eligible for a Barondess Fellowship in 2026-2028. No more than one candidate per institution per application cycle is permitted to apply for the Fellowship.

Application Submission and Review

The applications will be submitted online, with a deadline of Tuesday, December 16. The Fellowship Committee will review all applications and select the awardee for 2026-2028. Applicants are asked to provide a personal statement that addresses the following questions: 1) Why do I want the Barondess Fellowship? and 2) What would the Fellowship mean to me? They are also asked to address how the Fellowship will have a lasting impact on the institution’s internal medicine program. In addition to a primary focus on the fundamental clinical skills, candidates may wish to include consideration of the impacts on educational and training programs of new factors in the clinical environment, such as the increase in remote access to care through telehealth and the use of electronic communication between doctor and patient.

The award will be $50,000 ($25,000 per year for two years). The Fellowship requires an institutional commitment of .20 FTE for the awardee, but the Fellowship recognizes that the available funding will not fully support the awardees required time and effort (.20 FTE). The funds from the award can only be used for the awardee’s FTE. Progress Reports will be required at the end of Years 1 and 2.

Apply Now

Note: Cover letters will not be considered for review by the Selection Committee.

The application includes sections a) & b) to be completed by the candidate; c) the candidate’s department chair; and d) a letter of support from the internal medicine program director. Completion of all sections is required.

For additional Information, contact: [email protected] Office of the Fellows

The application should work in all browsers. We recommend that you use Firefox, Chrome or Internet Explorer.

---

Current & Previous Recipients

2025-2027

Jessica Lichter, MD
Simulation with AI for Improving Communication Skills for Internal Medicine Residents.
New Your City Health + Hospitals public health system located in the Borough of Queens, an affiliate of the Icahn School of Medicine at Mount Sinai

Shyam Sundaresh, MD
A Novel Implementation of Direct Observation to Teach Mental Health Communication Skills for Internal Medicine Residents.
Icahn School of Medicine at Mount Sinai

2024-2026

Emily Murphy, MD
Integrating Social Determinants of Health into Clinical Reasoning
Research conducted at John Hopkins University School of Medicine

2023-2025

Daniel Sartori, MD
Developing a virtual standardized patient program to teach and assess trainees’ clinical skills in the telemedicine era
Research conducted at New York University Grossman School of Medicine, NYU Langone Hospital—Brooklyn

Jacqueline Birnbaum, MD
Development and implementation of a curriculum on inter-visit care in the ambulatory setting
Research conducted at the University of Texas Health Science Center at Houston

2022 – 2024

Danielle L. Clark,  MD
Utilizing quality improvement methods to improve patient-centered bedside rounds in the COVID-19 era
Research Conducted at the University of Cincinnati Medical Center

2021-2023

Angela Orozco, MD
Longitudinal curriculum that improves residents’ clinical care provided to individuals with Limited English Proficiency (LEP)
Research conducted at Johns Hopkins University School of Medicine

2020-2022

Justin Berk, MD, MPH, MBA
Development and testing of podcasting programming as an innovative medium for knowledge dissemination to medical students and trainees
Research conducted at the Warren Alpert School of Medicine at Brown University

2019-2021

Chelsea Hook Chang, MD
Development of an innovative curriculum for the Barondess Elective-Advanced Clinical Reasoning
Research conducted at the University of Texas Rio Grande Valley School of Medicine

2018 – 2020

Bethany Brisbin Lockwood, MD
An innovative program with patient- centered aims related to the clinical transaction that focuses on interpersonal skills to impact patient and physician outcomes
Research conducted at The Ohio State University Wexner Medical Center

2017 – 2019

Reza Sedighi Manesh, MD
Examining the use of the Human Diagnosis Project ( Human Dx) as a scalable and objective measure of clinical reasoning
Research conducted at Johns Hopkins University School of Medicine

2016 – 2018

Brian Garibaldi, MD
Improving Cardiopulmonary Physical Examination Skills
Research conducted at Johns Hopkins University School of Medicine

Background

The New York Academy of Medicine Academic Research Award in Dermatology provides funding for residents and early-career dermatologists performing basic science or clinical research relevant to the field of dermatology. Awards in the amount of up to $10,000 each are awarded on a competitive basis. These awards are intended to help the recipient further his or her academic career, and may serve as a basis for obtaining further/future funding. Preference will be given to third year residents enrolled in an accredited Dermatology training program or board eligible or certified dermatologists who have completed Dermatology residency training or fellowships within the previous two years.  Candidates are expected to conduct their research in a supervised research program in the greater New York area.

The New York Academy of Medicine Academic Research Awards will be awarded on the basis of scientific merit and the anticipated impact of the project on the field of Dermatology. Preference will be given to candidates who have demonstrated a clear intention of pursuing a career in academic medicine, and have no active funding.

Eligibility Requirements

Preference will be given to third year residents enrolled in an accredited Dermatology training program or board eligible or certified dermatologists who have completed Dermatology residency training or fellowships within the previous two years. Candidates are expected to conduct their research in a supervised research program in the greater New York area. Candidates should have received appropriate training in biomedical research or have a mentor available to instruction.  Candidates are encouraged to pursue research projects that extend beyond the startup period. Candidates must show evidence of institutional commitment for the individual’s career development. Additionally, eligible candidates are required to be a US citizen, permanent resident of the US or authorized to work in the US for the period of time covered by this proposed award. For those individuals who may not meet this criteria, please email the program at [email protected] and exceptional circumstances may be considered.

Application Process

Applicants must provide the following as part of their application:

1. Completed Application Cover Page
2. Objective of Research Project not to exceed (one) page
3. Research proposal not to exceed (five) pages which should include project title, applicant’s name, faculty mentor’s name, research site and budget outline.  The font should be Arial with a minimum 11 point type size.  The application will be judged on the student’s input and creativity.
4. Biographical sketch of the student, including research background, career goals and immediate goals for the research project
5. Documentation of mentor’s IRB or IACUC protocol approval or submission (if applicable) or waiver. The complete protocol is not required, only the appropriate approval or submission cover page. Approvals for pending protocols must be in place by the start of the grant. In the case of animal research, include a copy of the institution’s current HHS Animal Welfare Assurance approval or renewal letter, or a letter from the institution’s research administration office affirming that the animal facility complies with all federal standards and has been so certified.
6. Biographical sketch of faculty mentor. (Sample at http://grants.nih.gov/grants/funding/phs398/biosketchsample.doc)
7. Signed letter of support from faculty mentor, including the role of the candidate, a plan for the mentor’s direct supervision of the candidate’s research activities, a plan for the candidate’s career development, and how the goals of the candidate will be achieved. Mentors are discouraged from sponsoring more than one individual per award cycle
8. Letter of commitment from chairman and/or institution
9. Title page including an abstract, significance of abstract and a brief description of what will be accomplished and why it is important
10. Hypotheses and Specific Aims, stating a working hypothesis (or hypotheses) and the aims of the proposed studies.
11. Background and Preliminary Data of project including description of the reasoning behind the proposal in the context of existing scientific knowledge, and if applicable, must provide any preliminary evidence supporting the hypothesis.
12. Copies of Relevant Publications pertaining to research project
13. Experimental approach to research which must describe how specific aims in terms of methodology and experimental design will be addressed
14. Proposed budget including itemized list the principal components of your budget and sufficient justification and detail to allow critical evaluation by the committee
15. Professional shoulder-length photo in electronic format

To begin the application process, click on the link below. You will be asked to complete an eligibility quiz. Provided that you meet the program eligibility requirements, you will then be asked to register by creating a login and password. With your login and password, you will be able to access the online application, including the forms that you must upload and complete.

CLICK HERE TO APPLY ONLINE

The application should work in all browsers. We recommend that you use Firefox, Chrome or Internet Explorer.

Award Information

This award will be for a 24 month period and provides funding for residents and early-career dermatologists performing basic science or clinical research relevant to the field of dermatology. Awards in the amount of up to $10,000 each are awarded on a competitive basis. These awards are intended to help the recipient further his or her academic career, and may serve as a basis for obtaining further/future funding.  This award will be paid directly to the sponsoring institution in three installments, 60% at the beginning of the award, 30% following the receipt and approval of the midyear report and the remaining 10% following the receipt of the final report. Announcement of the successful applicants for this award will be announced in time for research projects to commence on July 1.  The award may not cover indirect or overhead costs, or be used towards salary support for the candidate.  Candidates are eligible to receive only one award under this program. Grant recipients are required to submit progress and financial reports to the Academy at the mid-point and end of the grant period. Failure to comply with reporting requirements may result in termination of the grant and refund of any award monies paid, and may negatively affect consideration of future applications from the grantee’s institution. In addition, it is expected that a paper on the research project suitable for publication in a peer-reviewed journal will be submitted. For all publications, acknowledgment must be made of support from The New York Academy of Medicine.

Contact information

Office of Fellowship and Research Endowments
The New York Academy of Medicine
1216 Fifth Avenue
New York, NY 10029-5202
Email: [email protected]

---

 

Current & Previous Recipients

2015

Andrea Suarez, MD
Weill Cornell Medical College
“The Role of SOX10 in Invasive Melanoma”